Enduring sexual dysfunction after treatment with antidepressants, 5 α -reductase inhibitors and isotretinoin: 300 cases
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To investigate clinical reports of post-SSRI sexual dysfunction (PSSD), post-finasteride syndrome (PFS) and enduring sexual dysfunction following isotretinoin. METHODS: Data from RxISK.org, a global adverse event reporting website, have been used to establish the clinical features, demographic details and clinical trajectories of syndromes of persistent sexual difficulties following three superficially different treatment modalities. RESULTS: We report on 300 cases of enduring sexual dysfunction from 37 countries following 14 different drugs comprised of serotonin reuptake inhibiting antidepressants, 5 α-reductase inhibitors and isotretinoin. While reports of certain issues were unique to the antidepressants, such as the onset of premature ejaculation and persistent genital arousal disorder (PGAD), there was also a significant overlap in symptom profile between the drug groups, with common features including genital anaesthesia, pleasureless or weak orgasm, loss of libido and impotence. Secondary consequences included relationship breakdown and impaired quality of life. CONCLUSIONS: These data point to a legacy syndrome or syndromes comprising a range of disturbances to sexual function. More detailed studies will require developments in coding systems that recognise the condition(s). Further exploration of these tardive sexual syndromes may yield greater understanding of tardive syndromes in general.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Controlled discontinuation studies [111, 113, 114] showed that rebound may occur following SSRI discontinuation.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [113]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In both studies [111, 113], patients treated with paroxetine had acute return of pre-treatment symptoms [10, 111, 113], while patients taking fluoxetine did not.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [113]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Safarinejad, M. R., & Hosseini, S. Y. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000195110.79027.3f · Cited by 171
RetractedSafety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation
Safarinejad, M. R. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31814b98d4 · Cited by 38
RetractedDiagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Organic Causes of Erectile Dysfunction in Men Under 40
Ludwig, W., & Phillips, M. (2014) · Urologia Internationalis · doi:10.1159/000354931 · Cited by 2,156
Persistent Sexual Side Effects of Finasteride for Male Pattern Hair Loss
Irwig, M. S., & Kolukula, S. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02255.x · Cited by 294
Persistent Sexual Side Effects of Finasteride: Could They be Permanent?
Irwig, M. S. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02846.x · Cited by 162
Safarinejad, M. R. (2008) · Journal of Urology · doi:10.1016/j.juro.2008.07.034 · Cited by 136
Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients
Melcangi, R. C., Santi, D., Spezzano, R., Grimoldi, M. G., Tabacchi, T., Fusco, M. L., Diviccaro, S., Giatti, S., Carrà, G., Caruso, D., et al. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.04.003 · Cited by 106
Melcangi, R. C., Caruso, D., Abbiati, F., Giatti, S., Calabrese, D., Piazza, F., & Cavaletti, G. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12269 · Cited by 102
Persistent Sexual Side Effects after SSRI Discontinuation
Csoka, A. B., & Shipko, S. (2006) · Psychotherapy and Psychosomatics · doi:10.1159/000091777 · Cited by 92 · cited 1×
“A previous paper in the literature described a male subject who developed severe tactile insensitivity of his chest and abdomen in addition to penile numbness after using citalopram; and a female subject who experienced a reduction of genital and nipple sensitivity on fluoxetine which only partially resolved after dis…”
BackgroundKiguradze, T., Temps, W. H., Yarnold, P. R., Cashy, J., Brannigan, R. E., Nardone, B., Micali, G., West, D. P., & Belknap, S. M. (2017) · PeerJ · doi:10.7717/peerj.3020 · Cited by 83
YILMAZ, U., TATLISEN, A., TURAN, H., ARMAN, F., & EKMEKCIOGLU, O. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)62078-0 · Cited by 81
Leiblum, S. R., & Goldmeier, D. (2008) · Journal of Sex & Marital Therapy · doi:10.1080/00926230701636205 · Cited by 81
Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
Basaria, S. S., Jasuja, R., Huang, G. T.-W., Wharton, W., Pan, H., Pencina, K. M., Li, Z., Travison, T. G., Bhawan, J., Gonthier, R., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2726 · Cited by 74
Safarinejad, M. R., & Hosseini, S. Y. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901384 · Cited by 68
Estèbe, J.-P., & Myers, R. R. (2004) · Anesthesiology · doi:10.1097/00000542-200406000-00026 · Cited by 65
Loreto, C. D., Marra, F. L., Mazzon, G., Belgrano, E., Trombetta, C. S., & Cauci, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100237 · Cited by 58
Giatti, S., Foglio, B., Romano, S., Pesaresi, M., Panzica, G., García‐Segura, L. M., Caruso, D., & Melcangi, R. C. (2015) · Neuroendocrinology · doi:10.1159/000442982 · Cited by 58
One hundred and twenty cases of enduring sexual dysfunction following treatment
Hogan, C., Le Noury, J., Healy, D., & Mangin, D. (2014) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-140617 · Cited by 51
Self-citationPremature Ejaculation Associated with Citalopram Withdrawal
Adson, D. E., & Kotlyar, M. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d214 · Cited by 50 · cited 1×
“There is a previous case report in the literature in which the subject developed premature ejaculation 4-5 days after discontinuing citalopram, which persisted for several weeks, resolved after citalopram was reintroduced, and reappeared on further discontinuation [17].”
BackgroundArafa, M. M., & Shamloul, R. M. (2006) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901469 · Cited by 48
Raap, D. K., Garcia, F., Muma, N. A., Wolf, W. A., Battaglia, G., & van de Kar, L. D. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37990-x · Cited by 46
Genital Anaesthesia Persisting Six Years after Sertraline Discontinuation
Bolton, J. M., Sareen, J., & Reiss, J. P. (2006) · Journal of Sex & Marital Therapy · doi:10.1080/00926230600666410 · Cited by 45
Reisman, Y. (2020) · BMJ · doi:10.1136/bmj.m754 · Cited by 44
Jackowich, R., Pink, L., Gordon, A., Poirier, É., & Pukall, C. F. (2018) · Journal of Sex & Marital Therapy · doi:10.1080/0092623x.2017.1321598 · Cited by 42
Waldinger, M. D., van Coevorden, R. S., Schweitzer, D. H., & Georgiadis, J. R. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.031 · Cited by 40
Jacobsen, N. W., Hansen, C. H., Nellemann, C., Styrishave, B., & Halling‐Sørensen, B. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.07.005 · Cited by 38
NTP‐CERHR Expert Panel Report on the reproductive and developmental toxicity of fluoxetine
Hines, R. N., Adams, J., Louis, G. M. B., Faber, W. D., Holson, J. F., Jacobson, S. W., Keszler, M., McMartin, K. E., Segraves, R. T., Singer, L. T., et al. (2004) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20014 · Cited by 35
Persistent Sexual Arousal Syndrome
Freed, L. (2005) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2005.00122.x · Cited by 34
Effects of isotretinoin on male reproductive system
Coleman, R., & MACDONALD, D. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92803-7 · Cited by 30
Colpi, G. M., Fanciullacci, F., Aydos, K., & Grugnetti, C. (2009) · Andrologia · doi:10.1111/j.1439-0272.1991.tb02494.x · Cited by 29
5-HT1A receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats
Rizzo, S. J. S., Pulicicchio, C. M., Malberg, J. E., Andree, T. H., Stack, G. P., Hughes, Z. A., Schechter, L. E., & Rosenzweig-Lipson, S. J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000406 · Cited by 25
Kauffman, R. P., & Murdock, A. (2007) · The Open Women's Health Journal · doi:10.2174/1874291200701010001 · Cited by 19
Montejo, A. L., Llorca, G., Izquierdo, J. A., Carrasco, J. L., Daniel, E., Pérez-Sola, V., Vicens, E., Bousoño, M., Sánchez-Iglesias, S., Franco, M., et al. (1999) · PubMed · Cited by 18
Research works printed but not linked: 2
- Bahrick AS, 2006, American Society for the Advancement of Pharmacotherapy Tablet, 7, 2
- Montejo AL, 1999, Actas Esp Psiquiatr, 27, 23
Cited by
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Antidepressant‐induced sexual dysfunction
Rothmore, J. (2020) · Medical Journal of Australia · doi:10.5694/mja2.50522 · Cited by 229
Mechanisms of Panax ginseng action as an antidepressant
Jin, Y., Cui, R., Zhao, L., Fan, J., & Li, B. (2019) · Cell Proliferation · doi:10.1111/cpr.12696 · Cited by 133
Post-finasteride syndrome: a surmountable challenge for clinicians
Traish, A. M. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.11.030 · Cited by 136
Post-finasteride syndrome: An emerging clinical problem
Diviccaro, S., Melcangi, R. C., & Giatti, S. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100209 · Cited by 108
Metadata
- Authors
- Healy, D., Le Noury, J., & Mangin, D.
- Affiliations
- Bangor University (GB)
- North Wales Department of Psychological Medicine, Bangor, Wales, UK
- David Braley and Nancy Gordon Chair of Family Medicine, Department of Family Medicine, McMaster University, ON, Canada
- Corresponding author
- Healy, David
- Venue
- International Journal of Risk & Safety in Medicine
- Publisher
- SAGE Publications
- Published
- 2018-08
- Volume
- 29
- Issue
- 3-4
- Pages
- 125-134
- ISSN
- 0924-6479 (ISSN-L)
- 1878-6847
- PMC
- PMC6004900
- OpenAlex
- W2802435708
- Semantic Scholar
- 980049ad9fc49be8e672a609bb94c4ef030b4cc7
- Cited by
- 81
- References
- 34
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 8 · 2023: 9 · 2022: 12 · 2021: 10 · 2020: 13 · 2019: 13 · 2018: 3
- FWCI
- 7.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- International Journal of Risk & Safety in Medicine (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- sexual dysfunction, antidepressants, selective serotonin reuptake inhibitors, finasteride, 5-alpha reductase inhibitors, isotretinoin, adverse drug reactions, premature ejaculation, persistent genital arousal disorder, low libido, erectile dysfunction, tardive syndromes, adverse event reporting
- MeSH terms
- Adolescent, Adult, Aged, Antidepressive Agents, Dermatologic Agents, Female, Humans, Libido, Male, Middle Aged, Product Surveillance, Postmarketing, Quality of Life, Sexual Dysfunction, Physiological, Isotretinoin, Young Adult, 5-alpha Reductase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.